UNSPSC 51263307: Ecastolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C26H33N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EEB95DS30P, chemically known as (- )-4-(3-((3,4-dimethoxy-phenethyl)amino)-2-hydroxypropoxy)-3-(5-isoxazolyl)butyranilide. but generally known as ecastolol, which bears US NIH Compound Identifier 208905. European Medicines Agency schedules Ecastolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06444MIG.

UNSPSC 51263307 Ecastolol, a Commodity code, covers pharmaceutical products that state and local governments procure for public health and emergency response programs. Based on recent solicitation activity, the code encompasses naloxone and drug deactivation systems purchased by county health departments to support community health initiatives and overdose response infrastructure. The issuing bodies soliciting under this code include county governments operating community health programs and emergency services divisions.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, at 2:00 pm. Vendors were required to submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, and meet E-Verify and drug-free workplace certification requirements. The contract carried a two-year initial term with an optional one-year renewal and was potentially funded through FEMA, introducing federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. The procurement did not specify explicit set-aside designations for disadvantaged enterprises.